Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Seminars in Oncology|December 29, 1998
Active immunization against cancer cells: impediments and advancesM P Velders, H Schreiber, W M KastLeukemia|April 24, 1999
Modulation of the immune response and tumor growth by activated RasS Weijzen, M P Velders, W M KastLeukemia|May 23, 2001
Prospect for immunotherapy of acute lymphoblastic leukemiaM P Velders, S A ter Horst, W M KastMethods in Molecular Medicine|February 11, 2012
Molecular characterization of melanoma-derived antigensM Visser, M P Velders, M P Rudolf, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 21, 2001
Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cellsD I Gabrilovich, M P Velders, E M Sotomayor, et al.Cancer Research|August 2, 2001
Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate miceD Yang, G E Holt, M P Velders, et al.Cell Adhesion and Communication|October 1, 1994
Evidence for a role of the epithelial glycoprotein 40 (Ep-CAM) in epithelial cell-cell adhesionS V Litvinov, H A Bakker, M M Gourevitch, et al.The Journal of Cell Biology|April 1, 1994
Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion moleculeS V Litvinov, M P Velders, H A Bakker, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 8, 2001
Pharmacokinetic differences between a T cell-tolerizing and a T cell-activating peptideS Weijzen, S C Meredith, M P Velders, et al.Current Opinion in Molecular Therapeutics|March 16, 2001
Papillomavirus virus-like particles as anticancer vaccinesD M Da Silva, M P Velders, M P Rudolf, et al.Pageof 3